skip to main
|
skip to sidebar
THE AMPYRA CHANNEL
NEWS & TIPS!
Saturday
VIDEO: Acorda Therapeutics (AMPYRA) CEO Ron Cohen on how the partial government shutdown affects the pharmaceutical industry
CLICK TO WATCH THIS 3 MINUTE VIDEO WITH THE CEO OF THE COMPANY THAT MAKES AMPYRA TALK ABOUT "NO NEW DRUGS"
Newer Post
Older Post
Home
Blog Archive
►
2016
(8)
►
May
(1)
►
March
(2)
►
February
(5)
►
2015
(16)
►
July
(1)
►
June
(3)
►
March
(1)
►
February
(1)
►
January
(10)
►
2014
(42)
►
April
(41)
►
February
(1)
▼
2013
(12)
▼
October
(7)
AMPYRA IMPROVES WALKING SPEED, WALKING ENDURANCE ...
Treatment with dalfampridine (AMPYRA) resulted in ...
ECTRIMS UPDATE #2: BIOGEN HAS 3 NEW MS TREATMENTS ...
VIDEO: Acorda Therapeutics (AMPYRA) CEO Ron Cohen ...
STUDY: AMPYRA (Dalfampridine) improves walking spe...
Tecfidera & Ampyra Show Potential for Quality of L...
A SERVICE DEVELOPMENT AUDIT OF FAMPRIDINE (AMPYRA)...
►
September
(2)
►
July
(2)
►
May
(1)
►
2010
(26)
►
May
(1)
►
April
(13)
►
March
(12)
